Carla Verri Department of Experimental Oncology and Molecular Medicine Fondazione IRCCS Istituto Nazionale dei Tumori Biography Publications Institution JoVE Articles Carla Verri has not added a biography. If you are Carla Verri and would like to personalize this page please email our Author Liaison for assistance. Publications Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Jun, 2017 | Pubmed ID: 28302568 MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma MiRNA Signature Microarrays (Basel, Switzerland). Jul, 2016 | Pubmed ID: 27600084 Novel Method to Detect MicroRNAs Using Chip-based QuantStudio 3D Digital PCR BMC Genomics. Oct, 2015 | Pubmed ID: 26493562 Circulating MicroRNA Signature As Liquid-biopsy to Monitor Lung Cancer in Low-dose Computed Tomography Screening Oncotarget. Oct, 2015 | Pubmed ID: 26451608 Recent Advances of MicroRNA-based Molecular Diagnostics to Reduce False-positive Lung Cancer Imaging Expert Review of Molecular Diagnostics. Jun, 2015 | Pubmed ID: 25924864 Therapeutic Use of MicroRNAs in Lung Cancer BioMed Research International. 2014 | Pubmed ID: 25309923 YAP1 Acts As Oncogenic Target of 11q22 Amplification in Multiple Cancer Subtypes Oncotarget. May, 2014 | Pubmed ID: 24810989 Assessment of Circulating MicroRNAs in Plasma of Lung Cancer Patients Molecules (Basel, Switzerland). Mar, 2014 | Pubmed ID: 24619302 Clinical Utility of a Plasma-based MiRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: a Correlative MILD Trial Study Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Mar, 2014 | Pubmed ID: 24419137 MicroRNA Signatures in Tissues and Plasma Predict Development and Prognosis of Computed Tomography Detected Lung Cancer Proceedings of the National Academy of Sciences of the United States of America. Mar, 2011 | Pubmed ID: 21300873 Elevated Levels of the Acute-phase Serum Amyloid Are Associated with Heightened Lung Cancer Risk Cancer. Mar, 2010 | Pubmed ID: 20087959 Plasma DNA Levels in Spiral CT-detected and Clinically Detected Lung Cancer Patients: a Validation Analysis Lung Cancer (Amsterdam, Netherlands). Nov, 2009 | Pubmed ID: 19744743 Fragile Histidine Triad Gene Inactivation in Lung Cancer: the European Early Lung Cancer Project American Journal of Respiratory and Critical Care Medicine. Mar, 2009 | Pubmed ID: 19096006 Plasma DNA Quantification in Lung Cancer Computed Tomography Screening: Five-year Results of a Prospective Study American Journal of Respiratory and Critical Care Medicine. Jan, 2009 | Pubmed ID: 18787214 MicroRNA Based Flüssigbiopsie: Die Erfahrung der Plasma MiRNA Signatur Klassifikator (MSC) für Lung Cancer Screening Mavis Mensah*1, Cristina Borzi*1, Carla Verri1, Paola Suatoni2, Davide Conte1, Ugo Pastorino2, Fortunato Orazio1, Gabriella Sozzi1, Mattia Boeri1 1Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 2Unit of Thoracic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori JoVE 56326 Cancer Research
MicroRNA Based Flüssigbiopsie: Die Erfahrung der Plasma MiRNA Signatur Klassifikator (MSC) für Lung Cancer Screening Mavis Mensah*1, Cristina Borzi*1, Carla Verri1, Paola Suatoni2, Davide Conte1, Ugo Pastorino2, Fortunato Orazio1, Gabriella Sozzi1, Mattia Boeri1 1Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 2Unit of Thoracic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori JoVE 56326 Cancer Research
